MigVax Ltd.

Grantee website Israel
Purpose
to support early evaluation of a novel technology that could be used with polio VLP-based vaccines to induce mucosal immunity, providing a non-infectious polio vaccine that would protect against transmission in the countries at highest risk
Division
Global Development
Date
SEPTEMBER 2024
Region served
GLOBAL
Committed amount
$546,018
Grant topic
Polio
Duration (months)
10
Grantee location
Israel
Program strategy page

More about our work

Our story

Learn about the origins of the foundation and the values that drive our work.

Our work

Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.

How we work

We are focused on results. Those that can be measured. And those measured in ways beyond numbers.